Journal of Comparative Effectiveness Research

Papers
(The H4-Index of Journal of Comparative Effectiveness Research is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Atezolizumab with chemotherapy in first-line treatment for metastatic urothelial cancer: a cost–effectiveness analysis49
Journal of Comparative Effectiveness Research : 2022 year in review46
MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapy38
Access in all areas? A round-up of developments in market access and health technology assessment: part 1036
Engaging veterans in the research process: a practical guide31
Long-term effectiveness and safety of ravulizumab in paroxysmal nocturnal hemoglobinuria: a plain language summary30
Economic burden of sickle cell disease in the United States: a retrospective analysis of a commercial insurance database27
Smart connected insulin dose monitoring technologies versus standard of care: a Canadian cost–effectiveness analysis26
Effect of home-based exercise programs with e-devices on falls among community-dwelling older adults: a meta-analysis26
Ataluren for the treatment of people living with nonsense mutation Duchenne muscular dystrophy: a plain language summary of Study 04125
Acute effects of resistance exercise with blood flow restriction on cardiovascular response: a meta-analysis25
Corrigendum22
Postoperative outcomes and anesthesia type in total knee arthroplasty in patients with obstructive sleep apnea22
Effectiveness and safety of asfotase alfa for people with hypophosphatasia: a plain language summary of three studies21
Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-naïve people with HIV-1: a systematic literature review and network meta-analysis20
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 2018
Lessons on the use of real-world data in medical device research: findings from the National Evaluation System for Health Technology Test-Cases17
Impact of surgical complications on hospital costs and revenues: retrospective database study of Medicare claims17
Costs associated with nonalcoholic steatohepatitis disease progression in Medicare patients: a retrospective cohort study17
0.070662975311279